From: Immunotherapy Bridge 2019 and Melanoma Bridge 2019: meeting abstracts
Patient overview | N (%) | Women (%) | Men (%) | |
---|---|---|---|---|
Cohort | 520 (100) | 249 (47.8) | 271 (52.2) | |
Genus | Women | 249 (47.8) | 249 (100) | 0 (0) |
Men | 271 (52.2) | 0 (0) | 100 (0) | |
Localisation | Colon dx | 241 (46.3) | 117 (46.9) | 124 (45.7) |
Transverse | 47 (9) | 23 (9.2) | 24 (8.8) | |
Colon sin | 41 (8) | 25 (19.1) | 16 (5.9) | |
Sigmoid | 182 (35) | 79 (31.7) | 103 (38.1) | |
Undetermined | 9 (1.7) | 5 (2.1) | 4 (1.5) | |
Stage | II | 230 (44.2) | 108 (43.4) | 122 (45.1) |
III | 290 (55.8) | 141 (56.6) | 149 (54.9) | |
Treatment | Surgery | 275 (52.9) | 136 (54.6) | 139 (51.2) |
Surgery + adj chemotherapy | 245 (47.1) | 113 (45.4) | 132 (48.7) |